Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G.
Minerva Ginecologica 31(7-8): 563-568
1979
ISSN/ISBN: 0026-4784 PMID: 481814 Document Number: 153546
Document emailed within 1 workday
Related Documents
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114Closon, M.T.; Verbeke, L.; Kains, J.P.; Tijtgat, J.; Schallier, D. 1995: Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer Anticancer Research 15(2): 591-595
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Umsawasdi, T.; Nilprabhassorn, P. 1978: Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer Journal of the Medical Association of Thailand 61(3): 158-161
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Pectasides, D.; Tsavdaridis, D.; Aggouridaki, C.; Tsavdaridou, V.; Visvikis, A.; Tsatalas, K.; Fountzilas, G. 1999: Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage Ii breast cancer patients Anticancer Research 19(4c): 3521-3526
Tanaka, Y.; Ohmori, Y.; Toki, T.; Okazaki, Y.; Ogoshi, S.; Ogawa, Y. 1995: A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen Nihon Geka Hokan. Archiv für Japanische Chirurgie 64(1): 15-22
Tucker, J.D.; Wyrobek, A.J.; Ashworth, L.K.; Christensen, M.L.; Burton, G.V.; Carrano, A.V.; Everson, R.B. 1990: Induction, accumulation, and persistence of sister chromatid exchanges in women with breast cancer receiving cyclophosphamide, adriamycin, and 5-fluorouracil chemotherapy Cancer Research 50(16): 4951-4956
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Cadman, E.C.; Glick, J.H.; Cross, J.; Horton, J.; Taylor, S.G. 1984: Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer Cancer Treatment Reports 68(6): 877-879
Holmes, F.A.; Yap, H.Y.; Esparza, L.; Buzdar, A.U.; Hortobagyi, G.N.; Blumenschein, G.R. 1984: Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer Seminars in Oncology 11(3 Suppl 1: 28-31
Vogelzang, N.J.; Bonomi, P.D.; Rossof, A.H.; Wolter, J. 1978: Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma Cancer Treatment Reports 62(10): 1595-1597
Asaumi, J. 1997: Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma In Vivo 11(2): 147-151
Mitsugi, K.; Yasutake, T.; Etoh, T.; Ishimaru, T.; Ueda, A.; Nakano, S.; Niho, Y. 1993: Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2387-2390
Brachetti, A.K.; Limburg, H. 1977: Ancillary chemotherapy in the primary treatment of carcinoma of the breast. on the growth pattern of carcinoma of the breast and the establishment of a new concept in treatment Geburtshilfe und Frauenheilkunde 37(2): 109-114
Mano, M.P.; Barengo, R.; Sinistrero, G.; Giurgola, L.; Sismondi, P. 1985: Bone marrow toxicity of chemotherapy combinations in operable carcinoma of the breast Minerva Ginecologica 37(6): 335-338
Moertel, C.G.; Engstrom, P.; Lavin, P.T.; Gelber, R.D.; Carbone, P.P. 1979: Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones" Surgery 85(5): 509-513
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Umsawasdi, T.; Chainuvati, T.; Hitanant, S.; Nilprabhassorn, P.; Viranuvatti, V. 1976: Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma Journal of the Medical Association of Thailand 59(8): 380-383